Eric M. Dube

Companies

• Travere Therapeutics, Inc.Board member Jan 8, 2019 to now¹
• Travere Therapeutics, Inc.Chief executive officer Jan 8, 2019 to now¹
• OnKure Therapeutics, Inc.Board member Apr 8, 2021 to Jun 8, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TTTravere Therapeutics, Inc. TVTX432,886 shares³$23.0M at $53.15Sep 17, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 17, 2026Sold 6,802 shares at $64.95 of Travere Therapeutics, Inc.³
• Sep 17, 2026Sold 101,691 shares at $64.59 of Travere Therapeutics, Inc.³
• Sep 17, 2026Exercised options 108,493 shares at $23.34 of Travere Therapeutics, Inc.³
• Sep 16, 2026Sold 96,125 shares at $63.64 of Travere Therapeutics, Inc.³
• Sep 16, 2026Sold 99,716 shares at $63.26 of Travere Therapeutics, Inc.³
• Sep 16, 2026Exercised options 195,841 shares at $23.34 of Travere Therapeutics, Inc.³
• Sep 15, 2026Sold 270 shares at $65.31 of Travere Therapeutics, Inc.³
• Sep 15, 2026Sold 3,102 shares at $63.64 of Travere Therapeutics, Inc.³
• Sep 15, 2026Sold 28,796 shares at $62.66 of Travere Therapeutics, Inc.³
• Sep 15, 2026Sold 63,498 shares at $61.99 of Travere Therapeutics, Inc.³
• Sep 15, 2026Exercised options 95,666 shares at $23.34 of Travere Therapeutics, Inc.³
• May 6, 2026Sold 22,500 shares at $43.95 of Travere Therapeutics, Inc.⁴
• May 4, 2026Exercised options 22,500 shares of Travere Therapeutics, Inc.⁴
• Apr 15, 2026Sold 20 shares at $42.66 of Travere Therapeutics, Inc.⁵
• Apr 15, 2026Sold 7,165 shares at $41.75 of Travere Therapeutics, Inc.⁵
• Apr 15, 2026Sold 56,815 shares at $41.01 of Travere Therapeutics, Inc.⁵
• Apr 13, 2026Granted 64,000 shares of Travere Therapeutics, Inc.⁵
• Apr 1, 2026Sold 25,098 shares at $31.46 of Travere Therapeutics, Inc.⁶
• Apr 1, 2026Sold 34,902 shares at $30.55 of Travere Therapeutics, Inc.⁶
• Apr 1, 2026Exercised options 60,000 shares at $15.46 of Travere Therapeutics, Inc.⁶
• Feb 20, 2026Sold 60,000 shares at $30.10 of Travere Therapeutics, Inc.⁷
• Feb 20, 2026Exercised options 60,000 shares at $15.46 of Travere Therapeutics, Inc.⁷
• Feb 3, 2026Sold 33,635 shares at $32.70 of Travere Therapeutics, Inc.⁸
• Feb 3, 2026Sold 66,452 shares at $32.06 of Travere Therapeutics, Inc.⁸
• Jan 31, 2026Granted 113,800 shares of Travere Therapeutics, Inc.⁸